JP2011505371A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505371A5 JP2011505371A5 JP2010536173A JP2010536173A JP2011505371A5 JP 2011505371 A5 JP2011505371 A5 JP 2011505371A5 JP 2010536173 A JP2010536173 A JP 2010536173A JP 2010536173 A JP2010536173 A JP 2010536173A JP 2011505371 A5 JP2011505371 A5 JP 2011505371A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- chain variable
- variable region
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000427 antigen Substances 0.000 claims 8
- 102000036639 antigens Human genes 0.000 claims 8
- 108091007433 antigens Proteins 0.000 claims 8
- 230000004048 modification Effects 0.000 claims 8
- 238000012986 modification Methods 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 206010005003 Bladder cancer Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000009164 Islet Cell Adenoma Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 206010022498 insulinoma Diseases 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 208000021255 pancreatic insulinoma Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical class NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Chemical class O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical class O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000010452 phosphate Chemical class 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99169007P | 2007-11-30 | 2007-11-30 | |
| PCT/US2008/084899 WO2009073524A2 (en) | 2007-11-30 | 2008-11-26 | Conjugates of anti-rg-1 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011505371A JP2011505371A (ja) | 2011-02-24 |
| JP2011505371A5 true JP2011505371A5 (OSRAM) | 2011-11-04 |
Family
ID=40427118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536173A Withdrawn JP2011505371A (ja) | 2007-11-30 | 2008-11-26 | 抗−ｒｇ−１抗体の複合体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20110020329A1 (OSRAM) |
| EP (1) | EP2211908A2 (OSRAM) |
| JP (1) | JP2011505371A (OSRAM) |
| KR (1) | KR20100101122A (OSRAM) |
| CN (1) | CN101951960A (OSRAM) |
| AR (1) | AR069746A1 (OSRAM) |
| AU (1) | AU2008331507A1 (OSRAM) |
| BR (1) | BRPI0819765A2 (OSRAM) |
| CA (1) | CA2707443A1 (OSRAM) |
| CL (1) | CL2008003525A1 (OSRAM) |
| CO (1) | CO6210734A2 (OSRAM) |
| EA (1) | EA201000921A1 (OSRAM) |
| IL (1) | IL206060A0 (OSRAM) |
| MX (1) | MX2010005683A (OSRAM) |
| NZ (1) | NZ586514A (OSRAM) |
| TW (1) | TW200930407A (OSRAM) |
| WO (1) | WO2009073524A2 (OSRAM) |
| ZA (1) | ZA201003729B (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570990C (en) * | 2004-07-16 | 2014-01-21 | Micromet Ag | Expression-enhanced polypeptides |
| JP5677970B2 (ja) | 2008-11-03 | 2015-02-25 | シンタルガ・ビーブイ | 新規ｃｃ−１０６５類似体およびその複合体 |
| NO3056203T3 (OSRAM) | 2010-04-21 | 2018-05-12 | ||
| IL299365A (en) | 2010-05-27 | 2023-02-01 | Genmab As | Monoclonal antibodies against 2HER |
| CA2800769C (en) | 2010-05-27 | 2021-11-02 | Genmab A/S | Monoclonal antibodies against her2 epitope |
| US8852599B2 (en) | 2011-05-26 | 2014-10-07 | Bristol-Myers Squibb Company | Immunoconjugates, compositions for making them, and methods of making and use |
| MX373458B (es) | 2014-01-10 | 2020-05-11 | Byondis Bv | Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina. |
| JP2017510548A (ja) * | 2014-01-29 | 2017-04-13 | シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドＳｈａｎｇｈａｉ Ｈｅｎｇｒｕｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | リガンド‐細胞傷害性薬物抱合体、その製造方法、およびその用途 |
| US11345757B2 (en) | 2017-07-31 | 2022-05-31 | Trishula Therapeutics, Inc. | Anti-CD39 antibodies |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912227A (en) * | 1984-02-21 | 1990-03-27 | The Upjohn Company | 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds |
| US4978757A (en) * | 1984-02-21 | 1990-12-18 | The Upjohn Company | 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds |
| US5332837A (en) * | 1986-12-19 | 1994-07-26 | The Upjohn Company | CC-1065 analogs |
| US5084468A (en) * | 1988-08-11 | 1992-01-28 | Kyowa Hakko Kogyo Co., Ltd. | Dc-88a derivatives |
| JP2598116B2 (ja) * | 1988-12-28 | 1997-04-09 | 協和醗酵工業株式会社 | 新規物質ｄｃ１１３ |
| JP2510335B2 (ja) * | 1989-07-03 | 1996-06-26 | 協和醗酵工業株式会社 | Ｄｃ―８８ａ誘導体 |
| US5187186A (en) * | 1989-07-03 | 1993-02-16 | Kyowa Hakko Kogyo Co., Ltd. | Pyrroloindole derivatives |
| WO1991016324A1 (en) * | 1990-04-25 | 1991-10-31 | The Upjohn Company | Novel cc-1065 analogs |
| US6214345B1 (en) * | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| CA2165819C (en) * | 1994-04-22 | 2005-12-27 | Nobuyoshi Amishiro | Dc-89 derivatives |
| JPH07309761A (ja) * | 1994-05-20 | 1995-11-28 | Kyowa Hakko Kogyo Co Ltd | デュオカルマイシン誘導体の安定化法 |
| US5871969A (en) * | 1996-02-12 | 1999-02-16 | Human Genome Sciences, Inc. | Nucleic acids encoding human neuronal attachment factor-1 |
| US6682902B2 (en) * | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
| KR20030033007A (ko) * | 2001-05-31 | 2003-04-26 | 코울터 파머수티컬, 인코포레이티드 | 세포독소, 약물전구체, 링커 및 이에 유용한 안정화제 |
| US20050014700A1 (en) * | 2001-09-07 | 2005-01-20 | Boger Dale L. | Cbi analogues of cc-1065 and the duocarmycins |
| US7091186B2 (en) * | 2001-09-24 | 2006-08-15 | Seattle Genetics, Inc. | p-Amidobenzylethers in drug delivery agents |
| JP4680902B2 (ja) * | 2003-07-22 | 2011-05-11 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Ｒｇ１抗体及びその使用 |
| WO2005112919A2 (en) * | 2004-05-19 | 2005-12-01 | Medarex, Inc. | Self-immolative linkers and drug conjugates |
| US7691962B2 (en) * | 2004-05-19 | 2010-04-06 | Medarex, Inc. | Chemical linkers and conjugates thereof |
| US7714016B2 (en) * | 2005-04-08 | 2010-05-11 | Medarex, Inc. | Cytotoxic compounds and conjugates with cleavable substrates |
| CN101312748A (zh) * | 2005-09-26 | 2008-11-26 | 梅达莱克斯公司 | 抗体-药物轭合物和使用方法 |
| CA2627190A1 (en) * | 2005-11-10 | 2007-05-24 | Medarex, Inc. | Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| EP2027153B1 (en) * | 2006-05-25 | 2014-04-30 | Bayer Intellectual Property GmbH | Dimeric molecular complexes |
-
2008
- 2008-11-26 CN CN2008801259196A patent/CN101951960A/zh active Pending
- 2008-11-26 WO PCT/US2008/084899 patent/WO2009073524A2/en not_active Ceased
- 2008-11-26 KR KR1020107014394A patent/KR20100101122A/ko not_active Withdrawn
- 2008-11-26 CA CA2707443A patent/CA2707443A1/en not_active Abandoned
- 2008-11-26 TW TW097145816A patent/TW200930407A/zh unknown
- 2008-11-26 EP EP08858236A patent/EP2211908A2/en not_active Withdrawn
- 2008-11-26 JP JP2010536173A patent/JP2011505371A/ja not_active Withdrawn
- 2008-11-26 AU AU2008331507A patent/AU2008331507A1/en not_active Abandoned
- 2008-11-26 NZ NZ586514A patent/NZ586514A/en not_active IP Right Cessation
- 2008-11-26 CL CL2008003525A patent/CL2008003525A1/es unknown
- 2008-11-26 AR ARP080105135A patent/AR069746A1/es not_active Application Discontinuation
- 2008-11-26 MX MX2010005683A patent/MX2010005683A/es not_active Application Discontinuation
- 2008-11-26 BR BRPI0819765 patent/BRPI0819765A2/pt not_active IP Right Cessation
- 2008-11-26 US US12/745,337 patent/US20110020329A1/en not_active Abandoned
- 2008-11-26 EA EA201000921A patent/EA201000921A1/ru unknown
-
2010
- 2010-05-25 ZA ZA2010/03729A patent/ZA201003729B/en unknown
- 2010-05-28 CO CO10064681A patent/CO6210734A2/es not_active Application Discontinuation
- 2010-05-30 IL IL206060A patent/IL206060A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011505371A5 (OSRAM) | ||
| ES2982012T3 (es) | Materiales biológicos y usos de los mismos | |
| RU2476441C2 (ru) | Cd19-связывающие средства и их применение | |
| JP2009505676A5 (OSRAM) | ||
| JP2020502271A5 (OSRAM) | ||
| JP2009506790A5 (OSRAM) | ||
| JP2010535713A5 (OSRAM) | ||
| JP2018070648A5 (OSRAM) | ||
| RU2018119296A (ru) | Конъюгаты антитела, содержащие агонисты толл-подобного рецептора | |
| JP2010531140A5 (OSRAM) | ||
| RU2013142004A (ru) | Конъюгаты "антитело-лекарственное средство" | |
| JP2015534579A5 (OSRAM) | ||
| JP2015527318A5 (OSRAM) | ||
| CA2595610A1 (en) | Antibodies directed to angiopoietin-2 and uses thereof | |
| JP2013518912A5 (OSRAM) | ||
| JP2010513303A5 (OSRAM) | ||
| JP2012522513A5 (OSRAM) | ||
| WO2021248048A9 (en) | Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof | |
| JP2015528818A5 (OSRAM) | ||
| JP2004534020A5 (OSRAM) | ||
| JP2016503295A5 (OSRAM) | ||
| JP2015534578A5 (OSRAM) | ||
| JP2017534253A5 (OSRAM) | ||
| JP2010511388A5 (OSRAM) | ||
| JP2014522850A5 (OSRAM) |